UPLIFT
What is Project UPLIFT for Epilepsy?
Project UPLIFT is an internet and telephone program using cognitive behavioral therapy and mindfulness to treat depression in people with epilepsy.
Why was Project UPLIFT created?
Depression is one of the most common psychiatric disorders among people with epilepsy. A review of studies shows that between 32-48% of people living with epilepsy also suffer from depression, impacting quality of life and family functioning more even than seizure frequency. Project UPLIFT was created to help people better understand and cope with depression.
How does Project UPLIFT work?
Project UPLIFT is a home-based program provided by a mental health professional who has completed a ten-week training course.
I am a mental health professional and would like to attend a training.
Great! We are currently accepting trainees from all states, but are particularly interested in the following states: AL, AK, HI, IN, IA, KY, LA, NE, NV, NM, OH, OK, OR, RI, SC, SD, TN, VT, and WV.
The ten-week training program is free and is made up of weekly one-hour conference calls. Free continuing education credits are offered upon full completion.
To register for the training please contact Emory University at 404-712-9267 or e-mail mew.uplift@gmail.com.
This activity is supported, in part, by Cooperative Agreement Number 1 NU58DP006256-01, funded by the Centers for Disease Control and Prevention.
Resources
Epilepsy Centers
Epilepsy centers provide you with a team of specialists to help you diagnose your epilepsy and explore treatment options.
Epilepsy Medication
Find in-depth information on anti-seizure medications so you know what to ask your doctor.
Epilepsy and Seizures 24/7 Helpline
Call our Epilepsy and Seizures 24/7 Helpline and talk with an epilepsy information specialist or submit a question online.
Tools & Forms
Download our seizure tracking app, print out seizure action plans, or explore other educational materials.
Related Stories
Press Releases
Briefing on Capitol Hill Urges More Government Action and Investment in the Epilepsies
Read Story
